Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China flag China · Delayed Price · Currency is CNY
127.15
+1.15 (0.91%)
At close: May 28, 2026

SHE:301093 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
220.43354.16399.65421.55145.511,872
Short-Term Investments
-80.2630.111,117144.21-
Trading Asset Securities
962.66845.32268.9340.911,379-
Cash & Short-Term Investments
1,1831,2801,2991,5801,6691,872
Cash Growth
-4.87%-1.46%-17.80%-5.31%-10.88%3101.97%
Accounts Receivable
285.82261.72249.7280.59265.46264.21
Other Receivables
1.271.41.321.011.411.75
Receivables
287.08263.12251.02281.6266.86265.96
Inventory
147.28154.14127.9594.57119.24133.82
Other Current Assets
32.839.7316.8916.3625.8817.48
Total Current Assets
1,6501,7071,6951,9722,0812,289
Property, Plant & Equipment
655.98647.3584.46546.32387.05273.89
Long-Term Investments
61.3633.1437.4737.0425.5-
Other Intangible Assets
82.0382.882.2960.9321.0621.19
Long-Term Deferred Tax Assets
14.2113.1810.998.354.262.29
Long-Term Deferred Charges
21.2321.8618.9125.8231.8429.14
Other Long-Term Assets
45.7947.0376.0960.6329.8817.02
Total Assets
2,5312,5522,5052,7122,5802,633
Accounts Payable
102.21112.83129.91115.93111.71126.7
Accrued Expenses
12.2620.7917.7623.5624.9522.9
Short-Term Debt
-----41.18
Current Portion of Long-Term Debt
18.56----
Current Portion of Leases
-1.410.6---
Current Income Taxes Payable
2.810.73.1512.020.748.08
Current Unearned Revenue
42.214.263.252.784.82
Other Current Liabilities
35.5742.416.7716.855.179.43
Total Current Liabilities
175.36186.35172.43171.61145.36213.11
Long-Term Debt
65.0480.04----
Long-Term Leases
-3.290.63---
Long-Term Unearned Revenue
48.8124.7722.221.6713.643.4
Long-Term Deferred Tax Liabilities
2.262.682.42.125.22-
Other Long-Term Liabilities
32.8558.3358.3330--
Total Liabilities
324.31355.47255.99225.4164.21216.51
Common Stock
164.2164.2127.08135.79134.67134.67
Additional Paid-In Capital
1,5471,5361,6351,8701,8391,839
Retained Earnings
527.27526.66491.75519.79442.6443.11
Treasury Stock
-34.9-34.9-7.75-38.94--
Comprehensive Income & Other
-0.08-0.05----
Total Common Equity
2,2042,1922,2462,4862,4162,416
Minority Interest
2.744.173---
Shareholders' Equity
2,2072,1972,2492,4862,4162,416
Total Liabilities & Equity
2,5312,5522,5052,7122,5802,633
Total Debt
83.5490.751.23--41.18
Net Cash (Debt)
1,1001,1891,2971,5801,6691,831
Net Cash Growth
-11.51%-8.36%-17.88%-5.31%-8.87%-
Net Cash Per Share
6.837.257.808.939.5313.21
Filing Date Shares Outstanding
164.1164.1163.13167.14175.07175.07
Total Common Shares Outstanding
164.1164.1163.13175.48175.07175.07
Working Capital
1,4751,5201,5221,8011,9352,076
Book Value Per Share
13.4313.3613.7714.1713.8013.80
Tangible Book Value
2,1222,1102,1632,4252,3952,395
Tangible Book Value Per Share
12.9312.8613.2613.8213.6813.68
Buildings
-411.76285.7282.41252.99252.99
Machinery
-663.71519.98478.95332.88304.21
Construction In Progress
-35.49200.93156.78136.1634.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.